Targeting survival signaling in heart failure

Current Opinion in Pharmacology

Volumn 5, Issue 2 SPEC. ISS., 2005, Pages 165-170

  Morissette, Michael R ^a   Rosenzweig, Anthony ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ESTROGEN; GLYCOPROTEIN GP 130; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; KALLIKREIN; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; ARTICLE; CELL DEATH; CELL FUNCTION; CELL SURVIVAL; DISEASE COURSE; DOWNSTREAM PROCESSING; ENZYME PHOSPHORYLATION; GENE TRANSFER; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM;

EID: 15044364112     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.01.004     Document Type: Review

References (51)

1. J. Narula N. Haider R. Virmani T.G. DiSalvo D.F. Kolodgie R.J. Hajjar U. Schmidt M.J. Semigran G.W. Dec B.-A. Khaw Apoptosis in myocytes in end-stage heart failure N Engl J Med 335 1996 1182-1189
2. G. Olivetti R. Abbi F. Quaini J. Kajstura W. Cheng J.A. Nitahara E. Quaini L.C. Di C.A. Beltrami S. Krajewski et al. Apoptosis in the failing human heart N Engl J Med 336 1997 1131-1141
3. H. Hirota J. Chen U.A. Betz K. Rajewsky Y. Gu J. Ross Jr. W. Muller K.R. Chien Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress Cell 97 1999 189-198
4. D. Wencker M. Chandra K. Nguyen W. Miao S. Garantziotis S.M. Factor J. Shirani R.C. Armstrong R.N. Kitsis A mechanistic role for cardiac myocyte apoptosis in heart failure J Clin Invest 111 2003 1497-1504
5. H. Yaoita K. Ogawa K. Maehara Y. Maruyama Attenuation of ischemia/ reperfusion injury in rats by a caspase inhibitor Circulation 97 1998 276-281
6. T.A. Holly A. Drincic Y. Byun S. Nakamura K. Harris F.J. Klocke V.L. Cryns Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo J Mol Cell Cardiol 31 1999 1709-1715
7. S. Chatterjee A.S. Stewart L.T. Bish V. Jayasankar E.M. Kim T. Pirolli J. Burdick Y.J. Woo T.J. Gardner H.L. Sweeney Viral gene transfer of the antiapoptotic factor Bcl-2 protects against chronic postischemic heart failure Circulation 106 2002 I212-I217
8. Q. Li B. Li X. Wang A. Leri K.P. Jana Y. Liu J. Kajstura R. Baserga P. Anversa Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy J Clin Invest 100 1997 1991-1999
9. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655-1657
10. C.P. Baines L. Wang M.V. Cohen J.M. Downey Myocardial protection by insulin is dependent on phospatidylinositol 3-kinase but not protein kinase C or KATP channels in the isolated rabbit heart Basic Res Cardiol 94 1999 188-198
11. G. Kulik A. Klippel M.J. Weber Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt Mol Cell Biol 17 1997 1595-1606
12. H. Dudek S.R. Datta T.F. Franke M.J. Birnbaum R. Yao G.M. Cooper R.A. Segal D.R. Kaplan M.E. Greenberg Regulation of neuronal survival by the serine-threonine protein kinase Akt Science 275 1997 661-665
13. B. Li M. Setoguchi X. Wang A.M. Andreoli A. Leri A. Malhotra J. Kajstura P. Anversa Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart Circ Res 84 1999 1007-1019
14. H. Oh Y. Fujio K. Kunisada H. Hirota H. Matsui T. Kishimoto K. Yamauchi-Takihara Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes J Biol Chem 273 1998 9703-9710
15. D. Camper-Kirby S. Welch A. Walker I. Shiraishi K.D. Setchell E. Schaefer J. Kajstura P. Anversa M.A. Sussman Myocardial Akt activation and gender: Increased nuclear activity in females versus males Circ Res 88 2001 020-027
16. R.D. Patten I. Pourati M.J. Aronovitz J. Baur F. Celestin X. Chen A. Michael S. Haq S. Nuedling C. Grohe et al. 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling Circ Res 95 2004 692-699
17. R. Fukazawa T.A. Miller Y. Kuramochi S. Frantz Y.D. Kim M.A. Marchionni R.A. Kelly D.B. Sawyer Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt J Mol Cell Cardiol 35 2003 1473-1479
18. S.V. Naga Prasad G. Esposito L. Mao W.J. Koch H.A. Rockman Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy J Biol Chem 275 2000 4693-4698
19. T. Matsui L. Li F. del Monte Y. Fukui T. Franke R. Hajjar A. Rosenzweig Adenoviral gene transfer of activated PI 3-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro Circulation 100 1999 2373-2379
20. T. Matsui J. Tao F. del Monte K.-H. Lee L. Li M. Picard T.L. Force T.F. Franke R.J. Hajjar A. Rosenzweig Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo Circulation 104 2001 330-335
21. D.P. Brazil J. Park B.A. Hemmings PKB binding proteins. Getting in on the Akt Cell 111 2002 293-303
22. R. Aikawa M. Nawano Y. Gu H. Katagiri T. Asano W. Zhu R. Nagai I. Komuro Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt Circulation 102 2000 873-879
23. S. Negoro H. Oh E. Tone K. Kunisada Y. Fujio K. Walsh T. Kishimoto K. Yamauchi-Takihara Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-Kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction Circulation 103 2001 555-561
24. H. Yin L. Chao J. Chao Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-GSK-3 and Akt-Bad-14-3-3 signaling pathways J Biol Chem 2004 EPub ahead of print
25. J.A. Romashkova S.S. Makarov NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling Nature 401 1999 86-90
26. K.M. Regula D. Baetz L.A. Kirshenbaum Nuclear factor-kappaB represses hypoxia-induced mitochondrial defects and cell death of ventricular myocytes Circulation 110 2004 3795-3802
27. R. Craig M. Wagner T. McCardle A.G. Craig C.C. Glembotski The cytoprotective effects of the glycoprotein 130 receptor-coupled cytokine, cardiotrophin-1, require activation of NF-kappa B J Biol Chem 276 2001 37621-37629
28. C.G. Nebigil N. Etienne N. Messaddeq L. Maroteaux Serotonin is a novel survival factor of cardiomyocytes: Mitochondria as a target of 5-HT2B receptor signaling FASEB J 17 2003 1373-1375
29. S.A. Cook T. Matsui L. Li A. Rosenzweig Transcriptional effects of chronic Akt activation in the heart J Biol Chem 277 2002 22528-22533
30. M.H. Cardone N. Roy H.R. Stennicke G.S. Salvesen T.F. Franke E. Stanbridge S. Frisch J.C. Reed Regulation of cell death protease caspase-9 by phosphorylation Science 282 1998 1318-1321
31. A. Brunet A. Bonni M.J. Zigmond M.Z. Lin P. Juo L.S. Hu M.J. Anderson K.C. Arden J. Blenis M.E. Greenberg Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 96 1999 857-868
32. S. Dimmeler I. Fleming B. Fisslthaler C. Hermann R. Busse A.M. Zeiher Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation Nature 399 1999 601-605
33. D. Fulton J.P. Gratton T.J. McCabe J. Fontana Y. Fujio K. Walsh T.F. Franke A. Papapetropoulos W.C. Sessa Regulation of endothelium-derived nitric oxide production by the protein kinase Akt Nature 399 1999 597-601
34. F. Gao E. Gao T.L. Yue E.H. Ohlstein B.L. Lopez T.A. Christopher X.L. Ma Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: The roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation Circulation 105 2002 1497-1502
35. D.A. Cross D.R. Alessi P. Cohen M. Andjelkovich B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785-789
36. H. Yin L. Chao J. Chao Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling Hypertension 43 2004 109-116
37. M. Juhaszova D.B. Zorov S.H. Kim S. Pepe Q. Fu K.W. Fishbein B.D. Ziman S. Wang K. Ytrehus C.L. Antos et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore J Clin Invest 113 2004 1535-1549
38. A. Seidman C. Hudis M.K. Pierri S. Shak V. Paton M. Ashby M. Murphy S.J. Stewart D. Keefe Cardiac dysfunction in the trastuzumab clinical trials experience J Clin Oncol 20 2002 1215-1221
39. D.L. Keefe Trastuzumab-associated cardiotoxicity Cancer 95 2002 1592-1600
40. L.P. Grazette W. Boecker T. Matsui M. Semigran T.L. Force R.J. Hajjar A. Rosenzweig Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes Implications for herceptin-induced cardiomyopathy J Am Coll Cardiol 44 2004 2231-2238
41. C. Communal M. Sumandea P. de Tombe J. Narula R.J. Solaro R. Hajjar Functional consequences of caspase activation in cardiac myocytes Proc Natl Acad Sci USA 99 2002 6252-6256
42. J. Narula P. Pandey E. Arbustini N. Haider N. Narula F.D. Kolodgie B. Dal Bello M.J. Semigran A. Bielsa-Masdeu G.W. Dec et al. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy Proc Natl Acad Sci USA 96 1999 8144-8149
43. J.W. Adams Y. Sakata M.G. Davis V.P. Sah Y. Wang S.B. Liggett K.R. Chien J.H. Brown G.W. Dorn II Enhanced Galphaq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure Proc Natl Acad Sci USA 95 1998 10140-10145
44. Y. Sakata B.D. Hoit S.B. Liggett R.A. Walsh G.W. Dorn II Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice Circulation 97 1998 1488-1495
45. A.L. Howes J.F. Arthur T. Zhang S. Miyamoto J.W. Adams I.G. Dorn E.A. Woodcock J.H. Brown Akt-mediated cardiomyocyte survival pathways are compromised by G alpha q-induced phosphoinositide 4,5-bisphosphate depletion J Biol Chem 278 2003 40343-40351
46. T. Matsui L. Li J.C. Wu S.A. Cook T. Nagoshi M. Picard R. Liao A. Rosenzweig Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart J Biol Chem 277 2002 22896-22901
47. S. Haq G. Choukroun H. Lim K.M. Tymitz F.F. del Monte J. Gwathmey L. Grazette A. Michael R. Hajjar T. Force et al. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure Circulation 103 2001 670-677
48. T. Aoyama T. Matsui M. Novikov J. Park B. Hemmings A. Rosenzweig Serum and glucocorticoid-responsive kinase-1 (SGK1) regulates cardiomyocyte survival and hypertrophic response. Circulation 2005 in press.
49. I. Bock-Marquette A. Saxena M.D. White J.M. Dimaio D. Srivastava Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair Nature 432 2004 466-472
50. S. Welch D. Plank S. Witt B. Glascock E. Schaefer S. Chimenti A.M. Andreoli F. Limana A. Leri J. Kajstura et al. Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice Circ Res 90 2002 641-648
51. W. Chao T. Matsui M.S. Novikov J. Tao L. Li H. Liu Y. Ahn A. Rosenzweig Strategic advantages of insulin-like growth factor-I expression for cardioprotection J Gene Med 5 2003 277-286